+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gemcitabine Hydrochloride Market 2024-2028

  • PDF Icon

    Report

  • 132 Pages
  • July 2024
  • Region: Global
  • TechNavio
  • ID: 5568345
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The gemcitabine hydrochloride market is forecasted to grow by USD 323.8 million during 2023-2028, accelerating at a CAGR of 7.08% during the forecast period. The report on the gemcitabine hydrochloride market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing cancer population drive market growth, growing preference for chemotherapy drugs in developing countries, and approval of new drugs fuels market growth.

The gemcitabine hydrochloride market is segmented as below:

By Type

  • Generic
  • Branded

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the robust R&D activities fueling pipeline as one of the prime reasons driving the gemcitabine hydrochloride market growth during the next few years. Also, novel treatment options coupled with new applications and increasing inorganic growth strategies likely to fuel market growth will lead to sizable demand in the market.

The report on the gemcitabine hydrochloride market covers the following areas:

  • Gemcitabine hydrochloride market sizing
  • Gemcitabine hydrochloride market forecast
  • Gemcitabine hydrochloride market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gemcitabine hydrochloride market vendors that include Apotex Inc., Biocon Ltd., Cipla Inc., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Emcure Pharmaceuticals Ltd., Fresenius Kabi AG, Ingenus Pharmaceuticals LLC, Intas Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Lianyungang Jinkang Pharmaceutical Technology Co. Ltd., Merck KGaA, Nichi Iko Pharmaceutical Co. Ltd., Pfizer Inc., Shilpa Medicare Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and ZHEJIANG HISUN PHARMACEUTICAL Co. Ltd. Also, the gemcitabine hydrochloride market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Gemcitabine Hydrochloride Market 2018 - 2022
Historic Market Size - Data Table on Global Gemcitabine Hydrochloride Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Generic - Market size and forecast 2023-2028
Chart on Generic - Market size and forecast 2023-2028 ($ million)
Data Table on Generic - Market size and forecast 2023-2028 ($ million)
Chart on Generic - Year-over-year growth 2023-2028 (%)
Data Table on Generic - Year-over-year growth 2023-2028 (%)
6.4 Branded - Market size and forecast 2023-2028
Chart on Branded - Market size and forecast 2023-2028 ($ million)
Data Table on Branded - Market size and forecast 2023-2028 ($ million)
Chart on Branded - Year-over-year growth 2023-2028 (%)
Data Table on Branded - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product / Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
11.4 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
11.5 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
11.6 Fresenius Kabi AG
Fresenius Kabi AG - Overview
Fresenius Kabi AG - Business segments
Fresenius Kabi AG - Key offerings
Fresenius Kabi AG - Segment focus
11.7 Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. - Overview
Intas Pharmaceuticals Ltd. - Product / Service
Intas Pharmaceuticals Ltd. - Key offerings
11.8 Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Overview
Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Product / Service
Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Key offerings
11.9 Nichi Iko Pharmaceutical Co. Ltd.
Nichi Iko Pharmaceutical Co. Ltd. - Overview
Nichi Iko Pharmaceutical Co. Ltd. - Product / Service
Nichi Iko Pharmaceutical Co. Ltd. - Key offerings
11.10 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.11 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
11.12 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Gemcitabine Hydrochloride Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Generic - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Generic - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Generic - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Generic - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Branded - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Branded - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Branded - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Branded - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 47: Chart on Geographic comparison
Exhibits 48: Data Table on Geographic comparison
Exhibits 49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 85: Market opportunity By Geographical Landscape ($ million)
Exhibits 86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2023 and 2028
Exhibits 88: Overview on criticality of inputs and factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Companies covered
Exhibits 92: Matrix on companies position and classification
Exhibits 93: Apotex Inc. - Overview
Exhibits 94: Apotex Inc. - Product / Service
Exhibits 95: Apotex Inc. - Key news
Exhibits 96: Apotex Inc. - Key offerings
Exhibits 97: Biocon Ltd. - Overview
Exhibits 98: Biocon Ltd. - Business segments
Exhibits 99: Biocon Ltd. - Key offerings
Exhibits 100: Biocon Ltd. - Segment focus
Exhibits 101: Eli Lilly and Co. - Overview
Exhibits 102: Eli Lilly and Co. - Product / Service
Exhibits 103: Eli Lilly and Co. - Key news
Exhibits 104: Eli Lilly and Co. - Key offerings
Exhibits 105: Fresenius Kabi AG - Overview
Exhibits 106: Fresenius Kabi AG - Business segments
Exhibits 107: Fresenius Kabi AG - Key offerings
Exhibits 108: Fresenius Kabi AG - Segment focus
Exhibits 109: Intas Pharmaceuticals Ltd. - Overview
Exhibits 110: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits 111: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits 112: Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Overview
Exhibits 113: Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Product / Service
Exhibits 114: Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Key offerings
Exhibits 115: Nichi Iko Pharmaceutical Co. Ltd. - Overview
Exhibits 116: Nichi Iko Pharmaceutical Co. Ltd. - Product / Service
Exhibits 117: Nichi Iko Pharmaceutical Co. Ltd. - Key offerings
Exhibits 118: Pfizer Inc. - Overview
Exhibits 119: Pfizer Inc. - Product / Service
Exhibits 120: Pfizer Inc. - Key news
Exhibits 121: Pfizer Inc. - Key offerings
Exhibits 122: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 123: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 124: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 125: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 126: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 127: Viatris Inc. - Overview
Exhibits 128: Viatris Inc. - Business segments
Exhibits 129: Viatris Inc. - Key news
Exhibits 130: Viatris Inc. - Key offerings
Exhibits 131: Viatris Inc. - Segment focus
Exhibits 132: Inclusions checklist
Exhibits 133: Exclusions checklist
Exhibits 134: Currency conversion rates for US$
Exhibits 135: Research methodology
Exhibits 136: Information sources
Exhibits 137: Data validation
Exhibits 138: Validation techniques employed for market sizing
Exhibits 139: Data synthesis
Exhibits 140: 360 degree market analysis
Exhibits 141: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global gemcitabine hydrochloride market: Apotex Inc., Biocon Ltd., Cipla Inc., DR Reddys Laboratories Ltd., Eli Lilly and Co., Emcure Pharmaceuticals Ltd., Fresenius Kabi AG, Ingenus Pharmaceuticals LLC, Intas Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Lianyungang Jinkang Pharmaceutical Technology Co. Ltd., Merck KGaA, Nichi Iko Pharmaceutical Co. Ltd., Pfizer Inc., Shilpa Medicare Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and ZHEJIANG HISUN PHARMACEUTICAL Co. Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is robust R&D activities fueling pipeline."

According to the report, one of the major drivers for this market is the increasing cancer population drive market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Apotex Inc.
  • Biocon Ltd.
  • Cipla Inc.
  • Dr Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • Emcure Pharmaceuticals Ltd.
  • Fresenius Kabi AG
  • Ingenus Pharmaceuticals LLC
  • Intas Pharmaceuticals Ltd.
  • Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
  • Lianyungang Jinkang Pharmaceutical Technology Co. Ltd.
  • Merck KGaA
  • Nichi Iko Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Shilpa Medicare Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • ZHEJIANG HISUN PHARMACEUTICAL Co. Ltd.

Related Topics

Related Reports

Gemcitabine Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Gemcitabine Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 93 Pages
  • Global
From
Gemcitabine Hydrochloride - Global Strategic Business Report - Product Image

Gemcitabine Hydrochloride - Global Strategic Business Report

  • Report
  • 380 Pages
  • Global
From
Gemcitabine (CAS 95058-81-4) Global Market Research Report 2024 - Product Image

Gemcitabine (CAS 95058-81-4) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Breast Cancer Therapeutics Market 2024-2028 - Product Image

Breast Cancer Therapeutics Market 2024-2028

  • Report
  • 168 Pages
  • Global
From
Doxorubicin Market 2024-2028 - Product Image

Doxorubicin Market 2024-2028

  • Report
  • 163 Pages
  • Global
From

About the Gemcitabine Hydrochloride Market

=== Gemcitabine Hydrochloride in the Lung Cancer Drugs Market === Within the realm of lung cancer therapeutics, gemcitabine hydrochloride stands as a notable chemotherapeutic agent. It is commonly used as a first-line treatment for non-small cell lung cancer (NSCLC), one of the two main types of lung cancer, and is also employed in various regimens for other types of malignancies. The drug functions by inhibiting DNA synthesis, leading to cell death, particularly in actively dividing cells, such as cancer cells. Gemcitabine may be utilized alone or in combination with other agents such as platinum-based drugs, to enhance efficacy. Its market presence is sustained by its established role in standard lung cancer treatment protocols and ongoing clinical studies evaluating its effectiveness in various treatment combinations and sequences. Its administration and dosage are typically tailored to individual patient factors, including type and stage of cancer, as well as overall health status. ### Companies in the Market ### Several pharmaceutical companies are involved in manufacturing and distributing gemcitabine hydrochloride. Some established players in the market include Eli Lilly and Company, Teva Pharmaceutical Industries, Fresenius Kabi Oncology, Pfizer Inc., Sun Pharmaceutical Industries, and Mylan N.V. These companies are engaged in providing the medication to healthcare providers and patients, ensuring the drug's accessibility for cancer treatment. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.